Materias dentro de su búsqueda.
Mostrando 1,241 - 1,260 Resultados de 6,219 Para Buscar '"leishmaniasis"', tiempo de consulta: 0.54s Limitar resultados
  1. 1241
    “…BACKGROUND: Miltefosine (Profounda, FL) is an oral alkylphospholipid drug which is approved by the Food and Drug Administration for the treatment of some species of New World cutaneous leishmaniasis. The maximal daily recommended dosage is 50 mg t.i.d for 28 days; yet there is some evidence that doses <2.5 mg/kg/day may be associated with lesser efficacy. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1662. Pushing the Dose: Miltefosine Treatment for a Supersized American with Cutaneous Leishmaniasis
  2. 1242
    Materias: “…Includes articles from the special issue “Novel therapies for cutaneous leishmaniasis”, pp. 106 - 179…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
  3. 1243
    “…The oral administration of dapsone (DAP) for the treatment of cutaneous leishmaniasis (CL) is effective, although serious hematological side effects limit its use. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Evaluation of Skin Permeation and Retention of Topical Dapsone in Murine Cutaneous Leishmaniasis Lesions
  4. 1244
    “…BACKGROUND: Leishmaniasis represents the important public health problem in the world. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Conducting International Diploma Course on Leishmaniasis and Its Control in the Islamic Republic of Iran
  5. 1245
    “…BACKGROUND: Cutaneous Leishmaniasis (CL) isn’t a lethal disease, but it has always been taken into consideration due to more involvement of patients with skin ulcers and its long-term treatment. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Epidemiological Study of Cutaneous Leishmaniasis in Neyshabur County, East of Iran (2011-2017)
  6. 1246
    “…In this study, to examine the pathological involvement of MRP14 during cutaneous and visceral leishmaniasis, wild-type (WT) and MRP14 knockout (MRP14KO) mice were infected with Leishmania major and L. donovani. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pathological roles of MRP14 in anemia and splenomegaly during experimental visceral leishmaniasis
  7. 1247
    “…Post–kala-azar dermal leishmaniasis may occur after successful treatment of visceral leishmaniasis and is characterized by macules, papules, or nodules in the skin, with varying size. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Three-Dimensional Optical Scanning in Post–kala-azar Dermal Leishmaniasis (PKDL)
  8. 1248
    “…Cutaneous leishmaniasis is a disease caused by various Leishmania spp., which are transmitted by phlebotomine sand flies. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Phlebotomine sand flies and Leishmania species in a focus of cutaneous leishmaniasis in Algeria
  9. 1249
    “…INTRODUCTION: Leishmaniasis is a zoonotic disease which is caused by protozoan parasites of the genus Leishmania. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Seroprevalence, Clinical, and Pathological Characteristics of Canine Leishmaniasis in a Central Region of Colombia
  10. 1250
    “…In order to assess the immunotherapeutic potential on canine visceral leishmaniasis of the Leishmune(®) vaccine, formulated with an increased adjuvant concentration (1 mg of saponin rather than 0.5 mg), 24 mongrel dogs were infected with Leishmania (L.) chagasi. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune(®) vaccine
  11. 1251
    “…It is noteworthy that the HIV / L. infantum coinfected patient with asymptomatic leishmaniasis was easily infectious to sand flies for a long time, despite being under continuous prophylaxis for leishmaniasis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Role of asymptomatic and symptomatic humans as reservoirs of visceral leishmaniasis in a Mediterranean context
  12. 1252
    “…BACKGROUND: Leishmania donovani-induced and sand fly-transmitted leishmaniasis is a growing health problem in Sri Lanka. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Insecticide susceptibility of the sand fly leishmaniasis vector Phlebotomus argentipes in Sri Lanka
  13. 1253
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Author Correction: Challenges in the serological evaluation of dogs clinically suspect for canine leishmaniasis
  14. 1254
    “…Prediction parameters of possible outcomes of canine leishmaniasis (CanL) therapy might help with therapeutic decisions and animal health care. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Mathematical Modelling Using Predictive Biomarkers for the Outcome of Canine Leishmaniasis upon Chemotherapy
  15. 1255
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Visceral Leishmaniasis diagnosis: a rapid test is a must at the hospital bedside
  16. 1256
    “…BACKGROUND: Human leishmaniasis, both visceral and cutaneous, has been reported in Morocco for centuries and constitutes a serious public health problem. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Risk Factors Associated with Leishmaniasis in the Most Affected Provinces by Leishmania infantum in Morocco
  17. 1257
    “…In this study, the Th1/Th2 cytokine profile in cutaneous leishmaniasis (CL) is evaluated. MATERIALS AND METHODS: This study was carried out in leishmaniasis clinic of CRTSDL, TUMS, during March 2018 to March 2019. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Immune response in cutaneous leishmaniasis patients with healing vs. non-healing lesions
  18. 1258
    “…Cancer, malaria, and leishmaniasis remain the deadly diseases around the world although several strategies of treatment have been developed. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Nanoparticles Formulations of Artemisinin and Derivatives as Potential Therapeutics for the Treatment of Cancer, Leishmaniasis and Malaria
  19. 1259
    “…INTRODUCTION: It is believed that delays in diagnosis and treatment of Visceral Leishmaniasis (VL) contribute significantly to the burden of VL lethality in Brazil. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Visceral leishmaniasis lethality in Brazil: an exploratory analysis of associated demographic and socioeconomic factors
  20. 1260
    “…BACKGROUND: Treatment failure and resistance to the commonly used drugs remains a major obstacle for successful chemotherapy against visceral leishmaniasis (VL). Since the development of novel therapeutics involves exorbitant costs, the effectiveness of the currently available antitrypanosomatid drug suramin has been investigated as an antileishmanial, specifically for VL,in vitro and in animal model experiments. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    In vivo experiments demonstrate the potent antileishmanial efficacy of repurposed suramin in visceral leishmaniasis
Herramientas de búsqueda: RSS